Clinical Trials Browser

Phase 2 × INDUSTRY × J591 monoclonal antibody × Clear all

NCT00040586 2007-01-22

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Phase 2 Completed

Prostatic Neoplasms